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On-chip enzymatic microbiofuel cell-powered
integrated circuits†
Andrew G. Mark, ‡a Emmanuel Suraniti,‡a Jérôme Roche,§a Harald Richter,b
Alexander Kuhn,cd Nicolas Mano*ed and Peer Fischer*af
A variety of diagnostic and therapeutic medical technologies rely on long term implantation of an
electronic device to monitor or regulate a patient's condition. One proposed approach to powering
these devices is to use a biofuel cell to convert the chemical energy from blood nutrients into electrical
current to supply the electronics. We present here an enzymatic microbiofuel cell whose electrodes are
directly integrated into a digital electronic circuit. Glucose oxidizing and oxygen reducing enzymes are
immobilized on microelectrodes of an application specific integrated circuit (ASIC) using redox hydrogels
to produce an enzymatic biofuel cell, capable of harvesting electrical power from just a single droplet of
5 mM glucose solution. Optimisation of the fuel cell voltage and power to match the requirements of
the electronics allow self-powered operation of the on-board digital circuitry. This study represents a
step towards implantable self-powered electronic devices that gather their energy from physiological fluids.
Introduction
The lack of a sustainable power source that can harvest en-
ergy from the physiological environment is one of the road-
blocks to developing electronic biomedical devices for long
term implantation. It is counterintuitive that, while physiolog-
ical fluids teem with energy rich molecules such as fats, aden-
osine triphosphate and glucose, the energy for contemporary
electronic implants is drawn instead from co-implanted man-
made batteries of limited capacity. The critical bridging tech-
nology is the enzymatic biofuel cell (EBFC) which, by means
of enzymes, converts physiologically produced substrates into
useful electrical power. Unfortunately, EBFCs currently suffer
from drawbacks such as short lifetime, low current densities
and limited voltage which often makes them incompatible
with the electrical demands of typical implants.1 This is par-
ticularly true for miniaturized devices whose small dimensions
can only accommodate microbiofuel cells (μBFC) with com-
mensurately reduced current capacity.
The key components of an enzymatic biofuel cell are the
oxidoreductases immobilized on the two electrodes. Electrons
are generated at the anode and consumed at the cathode
through enzyme-catalysed electro-oxidation and reduction.
The intrinsic properties of enzymes – high catalytic activity at
physiological temperature and pH, low overpotential for sub-
strate conversion and absence of reaction side products – are
well matched to the requirements for operation in vivo.2 Nat-
urally, the greatest efforts have been focused on the develop-
ment of BFCs that gather their energy from blood, mostly
targeting glucose and dioxygen as substrates due to their
availability.3 As a consequence, many EBFCs are based on
glucose-oxidizing enzymes like glucose dehydrogenase or glu-
cose oxidase (GOx) and dioxygen-reducing enzymes such as
bilirubin oxidase (BOD) or laccase.4 Sustained efforts in EBFC
development5 have recently led to enzymatic glucose/O2 BFCs
capable of powering biomedical devices in vitro6 and even
in vivo.7–9 However, because of their limited power output,
these devices still rely on large macroscale electrodes that are
decoupled from the devices themselves. EBFC stacking or
voltage up-conversion is also usually needed to satisfy the
voltage demand of electronics;10–12 this further limits minia-
turization and restricts real-world application.
Fortunately, the power characteristics of digital electronics
and enzymatic fuel cells have evolved along converging trajec-
tories: the power input demands of electronics have
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decreased, while the power generating capabilities of EBFCs
have increased.13,14 The drastic improvements seen in digital
electronics are due, in part, to the practice of very large scale
integration (VLSI). Modern devices have been made faster,
more reliable, and smaller by integrating billions of transis-
tors implementing diverse functional units into a single piece
of silicon. In bio-hybrid systems, closer integration between a
digital circuit and its EBFC power source can be expected to
yield similar gains and result in systems that are more robust,
less expensive, and smaller than existing discrete designs.
In this paper, we present a system which combines an
electronic device and the enzymatic micro biofuel cell that
powers it, directly into the same silicon chip (see Fig. 1). The
power source is a high-performance glucose/O2 enzymatic
μBFC and the circuit is a custom application specific inte-
grated circuit (ASIC) implementing a digital counter. The high
output potential of the μBFC and the low voltage requirement
of the circuit eliminate the need for voltage conversion. This
demonstrates a methodology for closer integration between
electronic and enzymatic systems which will ultimately lead
to improved power systems for electronic implants.
One of the major advances towards integrated EBFCs has
been the introduction of redox hydrogels to electronically
connect the active redox centres of enzymes to the electrode
surfaces.15 These allow current densities of ∼mA cm−2 by em-
bedding a high density of enzymes within a permeable 3D-
polymer matrix containing mobile redox mediators, usually
osmium complexes, tethered to the polymer backbone. This
ensures optimal electron transfer to the underlying metal
electrode, regardless of enzyme orientation.16 The redox po-
tentials of the osmium moieties can be tuned to optimize
electron transfer for each oxidoreductase while maximizing
the open circuit potential (OCP, the highest voltage that can
be reached, at zero current) of the BFC.17 The substrate speci-
ficity of enzymes, tightly bound to their respective electrodes,
permits operation without a separation membrane.
μBFCs based on redox hydrogels have demonstrated energy
harvesting from physiological fluid, including glucose solu-
tions,18 and recently even human blood.19 The latter have dem-
onstrated high power densities on the order of 100 μW cm−2,
thus opening the possibility of implantation.20 In addition,
integration of EBFCs has been demonstrated in the context
of self-powered sensors,21 and EBFCs have been proposed as
power sources for wearable electronics embedded in contact
lenses.22,23 Combined with a well-adapted preparation
method for μ-electrodes, this can be a facile route towards
μBFCs with high power densities, a requirement for direct
integration into miniaturized devices with limited surface
areas.24
Methods and materials
μBFC integrated logic circuit
Our device integrates two distinct functions, a μBFC power
source and a digital counter circuit, into a single die. The de-
vice is based on an IMS GFQ100 gate forest library,
implemented in 0.5 μm CMOS (IMS Chips, Stuttgart, Ger-
many) on a 4.6 mm square die. The chip uses a semi-custom
design methodology to realize arbitrary circuit function
within an ASIC. As seen in Fig. 1, for this work we have
implemented a generic four-bit ripple counter.
Following CMOS processing, the circuit is further func-
tionalized as illustrated in Fig. 2. The top face of the chip die
is coated with a silicon nitride barrier layer (Fig. 2b) and two
aluminum electrode foundations (0.8 μm × 1.2 mm × 3.6 mm,
Al : Cu : Si 99% : 0.5% : 0.5%) with connections to the perime-
ter wire bond pads. The electrode foundations are sputter
coated with 500 nm of Au, upon a 5 nm Ti adhesion layer
(Fig. 2c). The regions to be coated are defined by a mylar
shadow mask aligned to the electrode foundations. The chips
are then packaged into a ceramic IC carrier (CLCC84), with
electrical connections made by wire bonding to the package
(Fig. 2d and h). The bond wires are mechanically protected
with UV-polymerizable epoxy (NOA 65; Norland Optical,
Cranbury, NJ, USA), followed by a thin layer of silicone (CAF
4; Bluestar Silicones, Lyon, France) to define a watertight
macrowell (2.5 mm × 2.5 mm) which partially exposes the two
electrode faces (Fig. 2e).
Fig. 1 Simplified schematic of the integrated μBFC (left) and ripple counter (right). Components within the dashed area are integrated on the chip.
Current is generated by the enzymatic oxidation of glucose to gluconolactone at the anode, and reduction of dioxygen to water at the cathode.
The power supplied drives the counter which is composed of D-flip-flops (F1 to F4) that successively divide the frequency of the input signal DIN
at each stage of the output D1 to D4. O1–O4 are on-chip output drivers, B1–B4 are off-chip buffers (AD8244), and J1 and J2 are off-chip remov-
able jumpers that can decouple the source from the load during testing.
Finally, each microelectrode is defined by drop casting ac-
etone diluted nail lacquer (10 : 1; Wj-con) around a temporary
poly-dimethylsiloxane mask (PDMS; Sylgard 184; Dow
Corning Corporation, Midland, MI, USA). The masks
consisted of a ∅400 μm cured PDMS cylinder extruded from
a 10 μL pipet tip. Each mask is pressed into contact with the
gold electrode surface under visual control and subsequently
diluted nail lacquer is drop cast around it. After 5 minutes of
drying the mask is removed to reveal the exposed gold disk
electrode (Fig. 2f and i). Once the two microelectrodes are de-
fined, the surface is rinsed with Milli-Q water. The influence
of the distance between the two microelectrodes, which will
affect the internal cell resistance, was not explored. However,
because the μBFC operating current is extremely low (nA-
range) and because the ionic strength of the experimental
buffer is very high, ohmic losses in the electrolyte will be cor-
respondingly low, and the microelectrode placement is not
expected to be critical. This hybrid fabrication process is
well-adapted to rapid development of the proof-of-principle
system described here as it permits exploration of parameters
such as the electrodes size, which would be time-consuming
if undertaken using photolithographic microfabrication pro-
cesses. However, the important characteristics of the method
– a small exposed electrode area surrounded by an insulating
polymer layer – can be easily replicated using lithographic
techniques for future process streamlining and device
miniaturization.
Details of the final step of biofunctionalization (Fig. 2g)
are reported below. Testing and setup is simplified by segre-
gating the power and logic functions of the device: connec-
tions between them are made through the bond pads at the
chip perimeter (and ultimately through the pins on the pack-
age). This permits testing of the μBFC performance and logic
functions to be performed independently. Currently, connec-
tions between the two segments of the chip are made at the
package level, but the same processes can implement the
connections on-die. This will permit further miniaturization,
necessary for integration in a complete implantable device.
Test setup
A multipurpose custom printed circuit board serves as the
interface between the chip and the measurement instrumen-
tation. We mainly used it in two configurations: for electro-
chemical characterization of the microelectrodes, the board
was set up to allow direct connection of the bi-potentiostat to
each electrode independently. During digital circuit testing, a
Keithley 2000 high impedance multimeter (Tektronix, Beaver-
ton, OR, USA) monitored the μBFC working potential while a
Keithley 6487 picoammeter (Tektronix) measured its output
current. The counter input signal was a 400 mVpp square
wave supplied by an Agilent 33220A (Keysight, Santa Rosa,
CA, USA) function generator. The output signals from the
counter were buffered through a high input impedance
AD8244 amplifier (Analog Devices, Norwood, MA, USA) with
unity gain, and measured by a Tektronics TDS 2024C multi-
channel oscilloscope. Light falling on the device induces
photocarriers which lead to an increase in drain current by
Fig. 2 Construction process of the on-chip μBFC. Side (left) and front
(right) views. a) Integrated circuit die with CMOS components. b) De-
position of two independent aluminum electrodes (dark grey) and tita-
nium nitrate passivation layer (SiNx, light grey). c) Gold electrodes de-
fined by shadow deposition (orange). d) Wirebond connections
between IC and package. e) Encapsulation of wires and remaining alu-
minum by epoxy and silicone elastomer (green) to create a macrowell.
f) Gold microelectrodes defined by nailpolish (pink). g) Enzyme
functionalization: GOx (blue) and BOD (yellow) hydrogels. h) Photo-
graph of the wired gold electrodes before encapsulation (step d). i)
Photo of gold microelectrodes, visible as small exposed circles on left
and right region of chip (step f).
several orders of magnitude. Therefore, the device testing
was always carried out with the chip shrouded by aluminum
foil.
Electrochemical characterization
All solutions were prepared in Milli-Q water (18.2 MΩ cm),
with analytical grade reagents. Electrochemical measure-
ments were performed using a CH Instruments 760C bi-
potentiostat (CH Instruments, Austin, TX, USA), with a Ag/
AgCl (KCl 3 M) reference electrode (BASi, West Lafayette, IN,
USA) and a platinum wire counter electrode. A 1 mm thick
PDMS gasket with a 5 × 5 mm2 central well was used to seal
a larger (∼2 mL capacity) funnel-shaped glass well to the face
of the chip.
Characterization of microelectrodes
The cleanliness of the bare gold microelectrodes was con-
firmed by cyclic voltammetry (CV; −0.225 V to +1.6 V vs. Ag/
AgCl at 100 mV s−1) in 0.1 M H2SO4 (99%; Sigma-Aldrich, St.
Louis, MO, USA). These CVs show the expected shape of gold
oxide stripping with a reduction peak at +0.9 V (Fig. SI1a†).
The active gold surface areas of the microelectrodes were esti-
mated from the integrated charge of the peak using a conver-
sion factor of −390 μC cm−2.25 The measurements indicate
surface areas of 0.13 ± 0.01 mm2, corresponding to diameters
of 410 ± 20 μm. CVs at 2 mV s−1 with 5 mM RuĲNH3)6
3+(Cl3)
(98%; Sigma-Aldrich) in a 0.1 M NaCl buffer (Fig SI1b†) give
a complementary measurement of 423 ± 8 μm for the effective
diameter of the electrodes.26 The mean of the electrochemical
measurements of the electrode diameters, 416 ± 17 μm, is
in good agreement with the optical estimate of around
400 μm.
Microbiofuel cell preparation
Immediately before functionalization with the hydrogel, the
microelectrodes were cleaned and rendered hydrophilic by a
series of CVs in sulfuric acid, then rinsed with water and
dried for 30 minutes at room temperature. The two active en-
zymes are glucose oxidase (GOx) from Aspergillus niger, pur-
chased from Sigma and purified as reported earlier,27 and
bilirubin oxidase (BOD) from Magnaporthe oryzae produced
and purified as described in ref. 28. Enzyme immobilization
results from the formation of an electrostatic adduct between
the polyanionic enzymes and polycationic redox polymers.
The adduct is further strengthened by the addition of a cross
linker. The cross linker exhibits at its two ends epoxy groups
that can react with functional amino acids present at the sur-
face of enzymes and polymer backbone.24 Redox hydrogel
electrodes were prepared as reported earlier for both the an-
odic29 and cathodic sides.30
The anodic hydrogel consists in an aqueous solution of
55 wt% PVP Osĳ(1,1-dimethyl-2,2'biimidazole)2-2-[6 methyl-
pyrid-2yl] imidazole]2+/3+ with a redox potential of −30 mV vs.
Ag/AgCl,29 35 wt% GOx and 10 wt% polyethylene glycol 400
diglycidyl ether (PEGDGE; Polysciences, Inc., Warrington, PA,
USA), for a total mass concentration of 5.08 mg mL−1. The ca-
thodic hydrogel is composed of 62.6 wt% PAA-PVI-[OsĲ4,4′-
dichloro-2,2′-bipyridine)2Cl]
+/2+ with an apparent redox poten-
tial of +350 mV vs. Ag/AgCl, 30 wt% BOD from M. oryzae and
7.4 wt% PEGDGE,30 leading to a 6.26 mg mL−1 solution.
The electrodes were modified with the appropriate hydro-
gel solution in each microwell (Fig. 2g) in four successive
steps of 0.5 μL coatings separated by 10 minutes of drying at
room temperature. Dividing the total amount of deposited
hydrogel by the active gold surfaces gives respective loadings
of 7.46 and 9.21 mg cm−2 at the anode and cathode. Once de-
posited, the hydrogels were cured for 18 hours at 4 °C,
protected from dust, allowed to equilibrate under ambient
conditions for 45 minutes, and gently rinsed two times with
phosphate buffer before experiments were started.
μBFC characterization
All experiments were performed in an air-conditioned lab
with the temperature fixed at 19 °C. CVs at 100 and 5 mV s−1
were first performed in 100 mM phosphate buffer (PB) at
pH 7.2 using a typical three electrode configuration in the
absence of glucose and in argon-purged buffer for polymer
characterization. Electrocatalysis was performed in aerated
PB containing 5 mM glucose under quiescent conditions,
with neither convection nor oxygen bubbling. Power curves
were measured as reported earlier between +0.75 V and 0 V
at 5 mV s−1.19
Self-powered chip function
The potentiostat was unplugged and the test setup was
reconfigured for measuring the chip performance (see sec-
tion “test setup” above), so that the integrated μBFC powered
the logic function of the chip while the power and digital per-
formance were assessed. The μBFC was fuelled by a 50 μL
droplet of a 5 mM glucose solution in PB. The droplet was re-
placed every 2 h to minimize variations in glucose concentra-
tion due to evaporation. The binary counting function was
allowed to run continuously while every 30 minutes a trace of
the binary counting signal was recorded on the oscilloscope,
and the current and voltage at the μBFC output were mea-
sured with the picoammeter and voltmeter.
Results and discussion
Characterization of the digital circuit
The ASIC is a generic 4-bit ripple counter based on D-flip-
flops. Briefly, the circuit takes an externally supplied input
clock signal, and successively divides the input frequency f by
two for each successive output, D1–D4. Taken together, the
states of the output channels provide a binary count of the
number of clock pulses since the last reset or rollover. The
rated supply voltage for this architecture is VDD = 4.5–5.5 V
(NMOS/PMOS threshold voltage 0.8 V/0.9 V), at which it can
process input clock speeds in excess of 250 MHz. However,
because of its low power consumption design, it is able to
operate at a reduced clock rate, down to supply voltages as
low as 500 mV, well below threshold voltages. Typical power
characteristics at VDD = 700 mV and f = 60 Hz is a consump-
tion of ∼560 pW. However, below 700 mV the output signal
quality diminishes rapidly (see Fig. SI2†). This low voltage op-
eration, not exploited in general use, decreases the power re-
quirements into the range where enzymatic microbiofuel
cells are possible candidates for supplying power, even with-
out voltage boost conversion. The challenge is then to design
an on-chip fuel cell with sufficiently high output voltage to
power the chip.
Optimization and characterization of enzyme electrodes
The critical components of the μBFC are the enzyme micro-
electrodes, each composed of a redox hydrogel containing
the active enzyme and immobilized on the integrated Au
microelectrode. The construction of the hydrogel disk micro-
electrodes was optimized through a series of experiments
conducted on gold-coated glass slides which were prepared
in the same manner as the integrated chip electrodes. Short
circuit current and onset potentials (potential at which the
electrocatalysis starts) under μBFC working conditions were
studied as a function of the volume of deposited hydrogel for
anode and cathode (Fig. SI3†). For both electrodes, bell-
shaped curves as a function of the loading are obtained, as
expected in conditions of low substrate concentration and
quiescent conditions.31,32 An increase in hydrogel thickness
limits the mass-transport, slows down the electron diffusion
towards the electrodes and therefore decreases the current
density (Fig. SI3b†).
However, at the same time, as illustrated for example in
Fig SI3c† for the cathode, increasing the hydrogel thickness
permits an increase in the onset potential for O2 reduction
which will ultimately increase the OCP of the BFC. Since the
OCP is the crucial parameter in our system, high hydrogel
loadings were preferred.
Integrated μBFC characterization
Once cleaned and characterized, the bare Au on-chip
electrodes were functionalized with the optimized hydrogel
loading evaluated above. A series of CVs (100 mV s−1, Fig. 3a)
were recorded in argon-purged buffer solution without sub-
strates, to verify the presence and stability of the hydrogel
layer. They show well-defined and stable oxidation and reduc-
tion peaks at both anode and cathode, with mean potentials
of −27 mV (anode, blue) and +335 mV (cathode, green) vs. Ag/
AgCl, in agreement with the redox potential of each polymer.
The oxidation-to-reduction peak separations are in the order
of 90 mV (73 mV at the anode and 106 mV at the cathode)
and indicate good reversibility in both hydrogels. The biocat-
alytic performance of the microelectrodes were characterized
at low scan rate (5 mV s−1) in an aerated PB at 19 °C after the
addition of 5 mM glucose, in the absence of O2 bubbling or
convection.
As seen in Fig. 3b, well-defined catalysis could be observed
at both the anodic (blue) and cathodic (green) sides of the
μBFC on which oxidation of glucose and reduction of
dioxygen take place respectively. The CVs exhibit a typical
shape for mass-transport limited systems, with maximal cata-
lytic currents of 116 nA (85 ± 7 μA cm−2) at the anode and
−166 nA (122 ± 10 μA cm−2) at the cathode. The dominant
contribution to the uncertainties in current density comes
from the electrochemically measured microelectrode diame-
ter. Finally, the performance of the microelectrodes working
together as a complete μBFC power supply was determined
and the resulting polarization curve is shown in Fig. 3c
Fig. 3 Electrochemical characterization of the on-chip microbiofuel
cell. a) Under Ar, in the absence of substrate and at 100 mV s−1. b) Cat-
alytic currents at the anode (blue) and cathode (green) in the presence
of 5 mM aerated glucose solution, 19 °C, and no forced convection. c)
Polarization curve (black) and the corresponding power curve (red).
CVs at 5 mV s−1 vs. Ag/AgCl (b) or vs. anode (c) as a reference, in aer-
ated PB.
(black curve). The maximum current produced by the μBFC
is 116 nA and is limited by the anodic side as expected from
the independent current measurement (Fig. 3b). The corre-
sponding power curve (Fig. 3c, red curve) exhibits a maximum
of 39 nW (29 ± 2 μW cm−2) at a potential of +0.357 V, with an
OCP of 0.725 V. When done with a single deposition step of
0.6 μL of hydrogel, the on-chip μBFC exhibits almost the same
maximal power (36 nW) but with an OCP of only 0.63 V, which
demonstrates the importance of our 4 step deposition
protocol.
Self-powered logic operation
In the following we demonstrate the fully integrated self-
powered operation of the device. The chip was configured as
shown in Fig. 1 so that all power for the chip function was
supplied by the μBFC. Upon fuelling with a 50 μL droplet of
aerated 5 mM glucose solution the binary counter operation
was immediately observed.
After 20 minutes of operation, consumption was 1.17 nA
at 672 mV at an input clock rate of 50 Hz. This is in good
agreement with the corresponding measurement of 1.3 nA
from the polarization curve at this potential. Fig. 4a depicts
the binary output signals from all four stages of the counter
after 45 minutes of operation. Each channel shows the
expected division of waveform, with sharp transitions be-
tween the on–off states, and a high-state voltage of approxi-
mately 0.66 V, in good agreement with VDD = 0.659 V. The
50 Hz ripple superimposed on the high-state arises from
radiated mains power interference. At 100 Hz (Fig. 4b) the
output performance remains almost identical, but the
current consumption increases from 1.22 to 1.33 nA and the
supply voltage drops to 0.655 V. However, operation at
200 Hz (Fig. 4c) leads to strong degradation of the D1
channel signal because the on-chip output driver is too slow
for operation under these conditions. The internal logic is
still functioning as expected as shown by the correct wave-
forms from the downstream channels D2 to D4.
Long term experiments were performed to assess system
longevity. Output waveforms were collected every half hour,
and the glucose solution was replaced every 2 hours to limit
changes in glucose concentration due to evaporation. Consid-
ering a typical current of 1 nA, less than 40 pmol of glucose
were consumed in 2 hours, which represents a negligible
fraction of the 250 nmol contained in the droplet. After 8 h
of continuous operation there was very little degradation in
the output signal quality.
Fig. 5a compares the D4 output waveform at the start of
the experiment (dark blue) and after almost 7.5 h of continu-
ous operation (light blue). The later waveform shows an in-
crease in rise time due to the exponential dependence of the
PMOS transistor current on the supply voltage and a small
decrease in amplitude.
Fig. 5b shows the trend of the waveform amplitude
(extracted using a fitting process) during the experiment (see
also Fig. SI4† for other channels). The lower curve is the sig-
nal to noise ratio (noise being defined as the mean squared
deviation between the square-wave fit and the measured
signal) which remains approximately constant throughout.
The signal amplitude decreases by 14.2 mV h−1, consistent
with the trend exhibited by the supply voltage. Taking a
Fig. 4 Frequency performance under power of the integrated μBFC
showing output of channels D1–D4 of the digital counter. a) Input 50
Hz (1.22 nA, 0.659 V). b) 100 Hz (1.33 nA, 0.655 V). c) 200 Hz (1.71 nA,
0.646 V). Acquired after 45 minutes of continuous operation in a 50 μl
droplet of 5 mM glucose. Input signal 400 mVpp.
minimum usable output amplitude of 0.5 V, this gives a total
device lifetime of roughly 14 h. Again, the sequential deposi-
tion of hydrogels extended the system's lifetime, as demon-
strated by the counting signal at 7.5 h of operation (576 mV,
2.1 nA) which is almost superimposable with the one after
only 2 h 30 min for a one-step deposition BFC (573 mV,
0.3 nA).
The degradation of the signal over time is due to the sta-
bility of the μBFC. Post-experiment power curves indeed
showed a decrease in open circuit potential of 80 mV and a
90% drop in peak power after 25 hours of continuous opera-
tion (Fig. SI5a†). The anode was more affected by the long
operation than the cathode, as it exhibited a 90% loss in cat-
alytic current while the cathode diminished by only 50%. Al-
though the loss in current is usually due to enzyme instabil-
ity, in this case degradation of the hydrogel also contributes.
This is evidenced by the shift in potential that was observed
at both the anode and cathode (Fig. SI5b†) and also by the
increase in lifetime with the number of deposition steps.
Conclusions
In this contribution, we report the first example of an applica-
tion specific integrated circuit that embeds a dedicated enzy-
matic microbiofuel cell to supply its power. The low power
consumption (nW) and low input voltage (sub-V) requirements
of the circuit enable it to perform its logic operation under
continuous self-power for 14 hours. Over the course of the run
it consumed less than 0.3 nmol of glucose from a single drop
of quiescent solution at typical blood-glucose concentrations.
Clear improvements can be achieved by increasing the
drive strength of the output stages (O1–O4) to eliminate the
off-chip buffers B1–B4. Also, the ultimate goal of all-foundry
processing can be achieved in a MEMS add-on processing
line. This would allow lithographic definition of the Au
microelectrodes, and the use of a polyimide encapsulation.
Finally, the deposition of hydrogel in well-defined geometries
can be improved by adopting inkjet techniques. These im-
provements can all be expected to increase device robustness
and decrease device size.
Further miniaturization of the system does not represent
any conceptual difficulties and thus allows envisioning inte-
gration as the data processing part of a real biomedical im-
plant. For example, the current circuit has a footprint of only
322 × 22 μm2 – the vast majority of the silicon die is unused
– this means that, in principle, the electrodes are what limits
downscaling. Reducing the chip size to match the extent of
the electrodes, here ∅400 μm, would make the device small
enough to fit within a 22 gauge hypodermic needle. This
would permit implantation within a blood vessel or between
the brain's pia matter and arachnoid. Both blood and cere-
brospinal fluid are glucose-rich physiological fluids.4 For our
device such extreme downscaling would face difficulties in
die singulation, hydrogel application and alignment, and de-
vice handling. But conventional batteries would be difficult
to adapt to such applications because miniaturizing them is
complicated by the need for a case, separating membrane
and other components.3,24
The efficiency of electrodes of similar composition in human
blood samples has already been demonstrated and the im-
provement of their operational stability is in progress.19 The
higher temperatures experienced by an implanted device in vivo
are expected to improve system performance by increasing the
available μBFC current while simultaneously reducing the cir-
cuit's threshold voltage. Longevity remains the most important
concern; apart from engineering more stable enzymes,33 me-
chanical strengthening of the hydrogel, principally by increas-
ing the cross-linking, is one option to increase its lifetime. The
other approach is to cover the electrodes with a permeable
biocompatible polymer.34 This might sufficiently enhance the
operational stability of such self-powered ASICs to the point
that they can be used as implantable biomedical devices.
Fig. 5 Long term counting performance under integrated biofuel cell
power. a) Output waveform of the D4 channel after 0 (dark blue) and
7.4 h (light blue) of continuous device operation in one droplet. b) The
output amplitude of the D4 signal (magenta) over 8 h of continuous
operation. The amplitude decreases concomitantly with the BFC
output potential. The signal to noise ratio (grey) remains roughly
constant.
The binary counter presented here stands as a proxy for
more complex functions that can be implemented with the
same low-voltage CMOS circuitry. However, even simple
counters are useful for recording data from sensors whose
output can be used as the clock signal. Examples include
temperature or capacitance transducers based on ring oscilla-
tors whose output is encoded in the frequency of a binary sig-
nal akin to the clock signal used here. In fact, these types of
sensors could even be fabricated alongside the counter itself
in the same silicon die, and with minimal additional circuitry
or power requirements. Increasing the storage capacity of the
counter results in only small increases in energy consump-
tion since the activity of each added stage is only half of its
predecessor. RF-ID is a natural candidate for device readout
since it is non-contact and self powered. The two power
sources complement one another: the μBFC supplies low
power for sensing and recording over many weeks or months,
and the RF-ID link supplies the intermittent high power nec-
essary during data downlink. Our system could then fulfill
Heller's vision of microbiofuel cells powering “miniature au-
tonomous sensor-transmitter packages which would broad-
cast for a few weeks the local temperature of a site, indicative
of local inflammation”.24
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